Magny-Vernois
34 rue du chêne Sainte Anne
Lure 70204
France
33 3 84 62 55 55
https://www.vetoquinol.com
Settore/i:
Settore:
Impiegati a tempo pieno: 2.440
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Alain Masson | Deputy CEO & Pharmacist Manager | 196,16k | N/D | 1962 |
Mr. Matthieu Frechin | CEO & Non-Independent Chairman of the Board | 490,68k | N/D | 1969 |
Mr. Regis Vimal du Monteil | Chief Financial Officer | N/D | N/D | 1965 |
Mr. Dominique Derveaux | Chief Operations Officer | 382,12k | N/D | 1969 |
Philippe Gruet | Chief Scientific Officer | N/D | N/D | N/D |
Sandrine Perrier | Chief Information Officer | N/D | N/D | N/D |
Laurent Thore | Director of Partnerships, Legal Affairs & Risks | N/D | N/D | N/D |
Xavier Berthet | Director of Group Communications | N/D | N/D | N/D |
Ms. Isabelle Proust-Cabrera | Group Director of Human Resources | N/D | N/D | N/D |
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
L'ISS Governance QualityScore di Vetoquinol SA al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.